Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Cleerly
CleerlyCleerly Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Cleerly match what happens in practice?
Public evidence
HeartFlow Files Patent Infringement Lawsuit Against Cleerly
SignalHunt:validation:HeartFlow
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 1 public external signal(s) across 1 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Cleerly through regulatory records, a published study, deployment evidence, company records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand Cleerly. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Cleerly is an AI-powered platform for coronary CT angiography analysis. It uses deep learning to measure and classify coronary plaque types.According to Cleerly
What Cleerly states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The platform identifies and characterizes non-calcified or low-density plaque in coronary arteries.
According to Cleerly
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
HeartFlow Files Patent Infringement Lawsuit Against Cleerly
Reported publicly
How widely is this actually used?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
Cleerly is an FDA-cleared AI-powered cardiac imaging platform that analyzes coronary CT angiography (CCTA) scans to quantify atherosclerotic plaque burden and characterize plaque composition — capabilities that go far beyond traditional calcium scoring and visual stenosis assessment.
The platform uses deep learning…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
Key strength
Regulatory: FDA cleared
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Cleerly accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence